Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection.
null nullGuido BertoliniGiovanni NattinoCarlo TasciniDaniele PooleBruno ViaggiGreta CarraraCarlotta RossiDaniele CrespiMatteo MondiniMartin LangerGian Maria RossoliniPaolo MalacarnePublished in: Intensive care medicine (2018)
In low risk-of-death patients admitted to the ICU with a Klebsiella spp. infection, the appropriateness of empirical antibiotic therapy seemed uninfluential to eventual mortality, while it appeared to be crucial in high-risk ones. The use of piperacillin-tazobactam may be inappropriate in severe patients with ESCR-CS-K infection. CR-K is associated to a significant 20% increase of adjusted mortality, only for patients at higher risk of death.